Ryan Selkis is back with the 6th edition of his tome of crypto. “We cover all of the top investment themes, people to watch, policy developments, and technical breakthroughs that we expect will shape crypto in 2023. Onward.” ~ learn […]
Adam Mastroianni might have discovered a new human bias. Then, he did something very rare in the scientific community: he self-published his research. Then he wrote this post explaining why peer review, “the greatest scientific experiment in history failed”. His […]
I was saddened to read this Consumer Reports article that cuts across most chocolate brands. “For 23 of the bars, eating just an ounce a day would put an adult over a level that public health authorities and CR’s experts […]
Mobile ordering, dedicated drive-thrus, and AI-powered cashiers are becoming commonplace for big chains. ~ learn more
They have these at my local Whole Foods and I’ve always been a bit turned off by them. But maybe that’s a knee-jerk reaction? “Holding my hand a few inches over an Amazon One scanner next to the cash register […]
This was especially interesting to me because growing up I was taught that normal is 36.6℃, which translates to 97.9℉. Harvard Health Publishing makes the case for revising down from 98.6℉ thanks to evidence of “falling average body temperature over […]
This surprised even the researchers. “The cancer vanished in every single patient, undetectable by physical exam, endoscopy, PET scans or M.R.I. scans.” ~ learn more
“The team demonstrated that participants with lower levels of ET [ergothioneine] displayed poorer cognitive performance at the start of the study and an accelerated rate of decline in cognitive and functional abilities over the follow-up period.” ~ learn more
The best tests today require expensive brain imaging and a lumbar puncture. Although effective treatment options are limited, this would allow for earlier diagnosis and possibly more effective research. ~ learn more
Some children have a rare disease that leaves them with open wounds for years. “Reporting in The New England Journal of Medicine, the results of a Phase 3 double-blind, placebo-controlled trial are nothing short of spectacular.” ~ learn more